Home
Neil F. McFarlane, President and CEO: Zevra Therapeutics ZVRA Sell · Filed 02/02
Trade details
- Type
- Insider sale
- Amount
- $853,580
- Shares · price
- 91,000 sh · $9.38 a share
- Held after
- 364,350 sh
- Trade date
- 26/02/02
- Filed
- 26/02/02
- Days to filing
- 0 days
Sold 20.0% of holdings
- Share of holding sold
- 20.0%
Zevra Therapeutics trades, last 26 weeks
What else happened in Zevra Therapeutics around then
Filed or reported within 30 days of the trade day · 01/03~03/04Neil F. McFarlane's recent trades
- Neil F. McFarlane
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 planZevra Therapeutics
ZVRA
$125.2K
14,625 sh
$125.2K
Filed 02/10
Traded 02/09
- Neil F. McFarlane
Planned sale10b5-1 planZevra Therapeutics
Planned sale10b5-1 planZevra Therapeutics
ZVRA
$950.6K
105,625 sh
$950.6K
Filed 02/02
Traded 02/02
- Neil F. McFarlane
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 planZevra Therapeutics
ZVRA
$211K
19,500 sh
$211K
Filed 25/10/10
Traded 25/10/10
- Neil F. McFarlane
Planned sale10b5-1 planZevra Therapeutics
Planned sale10b5-1 planZevra Therapeutics
ZVRA
$211K
19,500 sh
$211K
Filed 25/10/10
Traded 25/10/10
- Neil F. McFarlane
Sell10b5-1 planZevra Therapeutics
Sell10b5-1 planZevra Therapeutics
ZVRA
$481.6K
61,273 sh
$481.6K
Filed 25/02/14
Traded 25/02/13